To Evaluate the Effect of Treatment on Glaucoma Patients on Vision and lntraOcular Pressure and Visual Field

Abstract

Aims: To evaluate the visual function in glaucomatous patient in (Maka Eye Complex) conceming the impact of the treatment (medication. surgery and laser) on the visual function (i.e. visual acuity. visual field) and IOP. Methods: The age of the patients was ranged between (18 - 80) years with obvious tendency for those between 40 — 60 years. 52% were males and 48% were females. A total of 300 patients with glaucoma underwent treatment and had different period of follow up ranging between (I - 50) months post treatment. from records (201 l - 2013) were included in this study. Before the treatment a detailed history were included. background personal data was taken. Refraction and best corrected visual acuity were obtained. lntraocular pressure (IOP) was measured by Goldman applanation monitor, the visual field of each patient was assessed by using an octopus. Follow up: Each patient was followed up monthly to assess the vision. visual field and IOP. The vision and [OP were taken in the first day before treatment and in the last day after treatment in different period in between (1 - S0) month. Best correct visual acuity (B.C.V), and IOP were compared with the pre treatment record visual field was measured post treatment. Result: 86% underwent medication. while 10% have laser treatment and 4% surgical treatment; all patients have a refractive error. 63% hypermetropia and 37% myope. The study showed that 39% of patients have no improvement. and 41% of patients had vision improvement. while 20% showed deterioration of vision in the RE. Fourty two percent 42% of patients were not improved. and 35% of patients had vision improvement, and 23% showed deterioration of vision in the LE. RE IOP: The range of IOP was found between (2 - 46) mm Hg with and obvious tendency (49%) to reading between (14 - 24) mm Hg. LE IOP: The range of IOP was between (2 - 52) mm Hg with and obvious predication (50%) to reading between (13 - 23) mm Hg. RE: 26% showed mild loss of visual field. 32% showed moderate loss while 42% showed marked loss. LE: 22% showed mild loss of visual field, 35% showed moderate loss while 43% showed marked loss.